Product Information

DOXEPIN 75 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.2235 per EA under NDC 62135056390. Its NADAC has been published 194 times since Mar 8, 2023.

FDA first approved this application on Sep 4, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DOXEPIN 75 MG CAPSULE

Doxepin Hydrochloride
$0.2235per EA

Strength

75 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135056390

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

DOXEPIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA210268

FDA Approved

9/4/2020

TE Code

AB

On Market Since

9/4/2020

Pharmacological Classes

Price Statistics

The NADAC for DOXEPIN 75 MG CAPSULE has been published 194 times since Mar 8, 2023, and over the history we have for it it has declined 53.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2235 per EA
All-time high$0.4813 (Mar 15, 2023)
All-time low$0.1614 (Mar 18, 2026)
52-week high$0.2237
52-week low$0.1614
Median price$0.2280
Average price$0.2529
Largest weekly change+46.9% (Jul 19, 2023)
Weeks tracked194
Tracking sinceMar 8, 2023

Price History

1W

-0.1%

1M

+13.7%

3M

+22.3%

6M

+19.1%

1Y

+19.4%

3Y

-33.7%

5Y

N/A

All

-53.6%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DOXEPIN 75 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 75 MG CAPSULE, manufactured by Chartwell RX LLC, is $0.2235 per EA (NDC 62135056390), effective Nov 18, 2026.

How has the price of DOXEPIN 75 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for DOXEPIN 75 MG CAPSULE has declined 53.6%. It has been tracked across 194 weekly CMS publications since Mar 8, 2023.

What are the highest and lowest recorded NADAC prices for DOXEPIN 75 MG CAPSULE?

Since Mar 8, 2023, the NADAC for DOXEPIN 75 MG CAPSULE has ranged from a low of $0.1614 (Mar 18, 2026) to a high of $0.4813 (Mar 15, 2023), with a median of $0.2280 per EA.

Are there cheaper alternatives to DOXEPIN 75 MG CAPSULE?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXEPIN 75 MG CAPSULE, is $0.2218 per EA — about 1% below DOXEPIN 75 MG CAPSULE.

Who manufactures DOXEPIN 75 MG CAPSULE?

DOXEPIN 75 MG CAPSULE (NDC 62135056390) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.